Instituto de Saúde Coletiva, Universidade Federal de Mato Grosso, Cuiabá, MT, Brasil.
Arq Bras Cardiol. 2009 Jun;92(6):437-42, 456-61, 472-8. doi: 10.1590/s0066-782x2009000600010.
Metabolic Syndrome (MS) is a cluster of predisposing factors for cardiovascular diseases and diabetes mellitus, whose epidemiological characteristics are poorly known at regional and national levels.
To estimate the prevalence of MS and its associated factors in a sample of patients with high blood pressure in the urban area of Cuiabá, Mato Grosso State.
This was a cross-sectional study (May to November 2007) in a sample of 120 patients with high blood pressure (aged > or = 20 years), paired by gender and selected by the systematic sampling of a source population of 567 patients with high blood pressure in Cuiabá. All patients answered to home inquiries to provide sociodemographic and life habits data. The following measurements were taken: blood pressure; body mass index (BMI); waist and hip circumferences; plasma glucose, insulin, and lipid levels; homeostasis model assessment-estimated insulin resistance (HOMA); C-reactive protein, uric acid and fibrinogen levels. High blood pressure criterion: average systolic blood pressure > or = 140 mmHg and/or diastolic blood pressure > or = 90 mmHg; and Metabolic Syndrome diagnosis according to the I Brazilian Directive for Metabolic Syndrome and the NCEP-ATP III criteria.
120 patients (60 women), with high blood pressure and an average age of 58.3 +/- 12.6 years, were analyzed. We found a MS prevalence of 70.8% (95%CI 61.8 to 78.8), predominantly among women (81.7% vs. 60.0%; p=0.009), with no difference between adults (71.4%) and elderly patients (70.2%). The multiple regression analysis showed a positive association between MS and BMI > or = 25 kg/m(2), insulin resistance and family history of high blood pressure.
A high prevalence of MS was observed among patients with high blood pressure living in Cuiabá, with a significant association with BMI > or = 25 kg/m(2), insulin resistance (HOMA index) and, especially, a family history of high blood pressure. These results suggest the need for deeper studies on this subject.
代谢综合征(MS)是心血管疾病和糖尿病的一系列易患因素,其在地区和国家层面的流行病学特征知之甚少。
评估马托格罗索州首府库亚巴市高血压患者样本中 MS 的患病率及其相关因素。
这是一项横断面研究(2007 年 5 月至 11 月),在库亚巴市 567 名高血压患者的源人群中,通过系统抽样选择了 120 名年龄>或=20 岁的高血压患者作为配对样本。所有患者均接受家庭询问,提供社会人口学和生活习惯数据。测量以下指标:血压;体重指数(BMI);腰围和臀围;血浆葡萄糖、胰岛素和血脂水平;稳态模型评估估计的胰岛素抵抗(HOMA);C 反应蛋白、尿酸和纤维蛋白原水平。高血压标准:平均收缩压>或=140mmHg 和/或舒张压>或=90mmHg;根据巴西代谢综合征指南和 NCEP-ATP III 标准诊断代谢综合征。
分析了 120 名(60 名女性)患有高血压且平均年龄为 58.3 +/- 12.6 岁的患者。我们发现 MS 的患病率为 70.8%(95%CI 61.8 至 78.8%),主要发生在女性中(81.7%比 60.0%;p=0.009),成年人(71.4%)和老年患者(70.2%)之间无差异。多元回归分析显示,MS 与 BMI >或=25kg/m(2)、胰岛素抵抗和高血压家族史之间存在正相关。
库亚巴市高血压患者中 MS 的患病率较高,与 BMI >或=25kg/m(2)、胰岛素抵抗(HOMA 指数),尤其是高血压家族史显著相关。这些结果表明需要对此主题进行更深入的研究。